Evidence map›Paper›PMID 32796751›Full record

ArticleInternational journal of molecular sciences2020

Nusbiarylins Inhibit Transcription and Target Virulence Factors in Bacterial Pathogen

Adrian Jun Chu, Yangyi Qiu, Rachel Harper, Lin Lin, Cong Ma, Xiao Yang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. DisarmingPathogens (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. International journal of molecular sciences · 2023
    Article
  7. Article
  8. Ligand-Based Drug Design of Novel Antimicrobials againstInternational journal of molecular sciences · 2022
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Adrian Jun ChuDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.ORCID 0000-0001-9206-9395
Yangyi QiuState Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Hong Kong.
Rachel HarperDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.ORCID 0000-0001-9901-870X
Lin LinDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Cong MaState Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Hong Kong.ORCID 0000-0001-9245-0356
Xiao YangDepartment of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Chinese University of Hong Kong · HKHong Kong Polytechnic University · HK

Funding

Chinese University of Hong Kong Faculty of Medicine Faculty Innovation Award FIA2018/A/03Food and Health Bureau 19180052Hong Kong Polytechnic University G-YBYY, 1-ZVPS, large equipment fund, and the State Key Laboratory of Chemical Biology and Drug DiscoveryResearch Grants Council, University Grants Committee PolyU 151000/19M, CUHK 141659/17M and 141079/19M
6 · The paper itself

Abstract

The emergence of multidrug resistance in the clinically significant pathogen

Indexed as

Transcription, GeneticAdenosine TriphosphateAnimalsAnti-Bacterial AgentsBacterial ProteinsErythrocytesExotoxinsGene Expression Regulation, BacterialGenes, EssentialHemolysisKineticsMicrobial Sensitivity TestsRabbitsRifampinStaphylococcus aureusTime FactorsAdenosine TriphosphateAnti-Bacterial AgentsBacterial ProteinsExotoxinsRifampinVirulence Factorsantibioticantimicrobial agentdrug discoveryMRSAnusbiarylinStaphylococcus aureus

Identifiers

PMID32796751
PMCPMC7461214
OpenAlexW3048689927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.